Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Generation and characterization of humanized mice carrying COMT158 Met/Val alleles.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2014

The Val158Met polymorphism of human catechol-o-methyltransferase (COMT) is one of the most well-studied single-nucleotide polymorphisms in neuropsychiatry; however, findings are inconsistent due to human genetic heterogeneity. We created the first 'humanized' COMTVal158Met mouse lines, which carry either human COMT Val or Met alleles via gene targeting. The 'humanized' mouse model enables strict comparison of the physiological functions of the two alleles. Consistent with human observation, Met/Met mice exhibited a 30% reduction in enzymatic activity compared with Val/Val mice. On the basis of the reported differences in human Met and Val carriers across working memory, fear processes and sensorimotor gating, we examined these functions between sibling Met/Met and Val/Val mice. Val/Val mice exhibited robust reductions in spatial working memory compared with Met/Met mice in both sexes, with tolcapone treatment significantly reversing the Val/Val alternation deficits. Sex effects were observed in other behaviors, with male Val/Val mice exhibited lower prepulse inhibition compared with Met/Met mice, whereas female mice exhibited the opposite phenotype. Female but not male Met/Met mice exhibited reduced contextual fear, increased cued fear, and reduced extinction recall. Thus, these mice (1) support the argument that human COMT Val158Met polymorphism modulates behavioral functions and most importantly (2) exhibit the expected treatment effects supporting the 'inverted U shaped' dose response of catecholamine signaling on cognitive function. This model will be invaluable for understanding the effects of human COMT Val158Met polymorphism on cortical development and behavioral functions, and how this polymorphism modulates treatment response.

Pubmed ID: 24509724 RIS Download

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: PHS HHS, United States
    Id: NIMH042228
  • Agency: NCRR NIH HHS, United States
    Id: UL RR031980
  • Agency: PHS HHS, United States
    Id: NIMH083499
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH042228
  • Agency: NIMH NIH HHS, United States
    Id: R21 MH083499
  • Agency: NIMH NIH HHS, United States
    Id: MH073991
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR031980
  • Agency: NIMH NIH HHS, United States
    Id: R33 MH083499
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH073991

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


129-Comttm1(COMT)Xzho/J (organism)

RRID:IMSR_JAX:027990

Mus musculus with name 129-Comttm1(COMT)Xzho/J from IMSR.

View all literature mentions

129-Comttm2(COMT)Xzho/J (organism)

RRID:IMSR_JAX:027993

Mus musculus with name 129-Comttm2(COMT)Xzho/J from IMSR.

View all literature mentions